The present disclosure relates to an electronic label for a drug delivery device configured for administering a medicament to a patient. The electronic label includes a flexible substrate configured for attachment to a body. The electronic label further includes an electronic display located on the flexible substrate, wherein the electronic display is configured to display a first information content of a first information type, a second information content of a second information type, and a third information content of the first or of the second information type. The electronic label includes a processor connected to the electronic display, which is configured to modify or to control a visual appearance of the electronic display by visualizing at least a portion of the first information content and at least a portion of the third information content separately, simultaneously, sequentially or alternately on the electronic display.

The present disclosure refers to an injection device including a housing containing a dose setting mechanism, a cartridge holder containing a cartridge with a medicament, and a heat shrinkable label which includes information and/or symbols about the medicament. The injection device is a disposable injection device with the cartridge holder inseparably locked to the housing. The heat shrinkable label is heat shrunk on the housing and the cartridge holder such that it at least partially covers the housing and the cartridge holder.

A drug solution administration unit including a drug solution administration module having a first flow path unit, a second flow path unit, and a drive mechanism unit, and a drug solution administration device having a branch path and a main path. The first flow path unit includes an upstream side main body where a first flow path to store drive solution is formed, and the second flow path unit includes a downstream side main body where a second flow path to store drug solution is formed. The drive mechanism unit includes a pair of electrodes and a porous body sandwiched between the pair of electrodes, the drive mechanism unit has a connecting flow path connecting a downstream end of the first flow path and an upstream end of the second flow path.

Drug depot delivery devices and methods for delivering a drug depot to a site beneath the skin of a patient are provided. In various embodiments the device has a housing having a top housing end, and a bottom housing end. The housing defines a housing channel. The device has a drug cartridge defining a depot channel aligned with the housing channel and configured to slidably accept the drug depot. The drug cartridge has at least a first occluding device configured to occlude the depot channel at a first position such that the drug depot cannot pass through the depot channel without force applied to the drug depot sufficient to deflect the first occluding device. The bottom end of the housing has a coupling configuration for engaging a cannula. A plunger has a push rod to expel the drug depot through the occluding device and the cannula.

A medical pump includes a reader configured to read drug identification information, a storage unit that stores the drug identification information read by the reader, a notification unit, and a control unit, in which when the reader reads drug identification information anew while the drug identification information is stored in the storage unit, the control unit compares the drug identification information being stored in the storage unit with the drug identification information read anew by the reader, and when the drug identification information being stored in the storage unit does not match the drug identification information read anew by the reader, the control unit causes the notification unit to notify of non-matching between drugs.

An IV set includes an IV component and a duration monitor device coupled to the IV component. The duration monitor device may include an indicator portion configured to change color after a determined amount of time upon activation of the indicator portion, or an RFID tag configured to be detected by an RFID reader. The duration monitor is configured to provide an indication of passage of a useful-life time period for the IV set or the IV component. Methods of operating a duration monitor device are also provided.

The present disclosure relates to a method of pairing an electronic data logging device of a drug delivery device with an external electronic device and to a respective drug delivery device. The drug delivery device comprises a housing configured to accommodate the medicament and to receive and/or mechanically engage with the electronic data logging device. The drug delivery device further comprises a first device component and a second device component. The first device component is movable relative to the second device component from a first positional state to a second positional state. The first device component comprises a first outer surface, and the second device component comprises a second outer surface. At least one of the first outer surface and the second outer surface comprises a first code portion of a pairing code for establishing a communication link between the electronic data logging device and an external electronic device.

Embodiments of negative pressure wound therapy systems, apparatuses, and methods for operating the systems and apparatuses are disclosed. In some embodiments, a medical device is configured to detect an identity of a patient-contacting disposable connected to the medical device. The medical device automatically modifies one or more operational parameters of the medical device based on the identity of the patient-contacting disposable connected to the medical device. The medical device can include a user interface and modify automatically available selections in the user interface based on the identity of the patient-contacting disposable connected to the medical device.

A fluid connector assembly. The fluid connector assembly includes a tab portion including a slot; a plug portion slidably connected to the tab portion the plug portion comprising a fluid path and a disc, the disc configured to seat within the slot; a catch feature located on a first end of the tab portion and configured to interact with a reservoir; and a latching feature located on a second end of the tab portion, the latching feature configured to interact and lock onto the reservoir, wherein force applied to the plug portion may overcome a threshold force and unseat the disc from the slot wherein the plug portion moves with respect to the tab portion.

A test fixture for testing aerosol provision devices may include a housing, a plurality of testing modules disposed at the housing where each of the testing modules includes a cavity configured to receive a portion of an aerosol provision device, and processing circuitry operably coupled to the testing modules. Each of the testing modules may be configured to interface with an assembly of a respective one of the aerosol provision devices to transition the assembly between an initial state and a transitioned state during a functional test controlled by the processing circuitry. The processing circuitry may be configured to conduct the functional test of at least two of the testing modules simultaneously.